These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS. Antivir Ther; 2003 Oct 07; 8(5):379-84. PubMed ID: 14640384 [Abstract] [Full Text] [Related]
15. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team. Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042 [Abstract] [Full Text] [Related]
16. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT. AIDS; 2006 May 12; 20(8):1171-9. PubMed ID: 16691069 [Abstract] [Full Text] [Related]
18. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A. AIDS; 2007 Jan 30; 21(3):351-9. PubMed ID: 17255742 [Abstract] [Full Text] [Related]
19. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis. Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W. Pediatrics; 2005 Apr 30; 115(4):e488-94. PubMed ID: 15772172 [Abstract] [Full Text] [Related]
20. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. J Infect Dis; 2004 Sep 15; 190(6):1046-54. PubMed ID: 15319852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]